{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:17:15Z","timestamp":1779020235629,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1053\/j.ajkd.2020.07.019","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:31:00Z","timestamp":1599737460000},"page":"861-867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Veverimer: An Emerging Potential Treatment Option for Managing the Metabolic Acidosis of CKD"],"prefix":"10.1053","volume":"76","author":[{"given":"Horacio J.","family":"Adrogu\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaos E.","family":"Madias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2020.07.019_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2019.01.036","article-title":"Metabolic acidosis in CKD: core curriculum 2019","volume":"74","author":"Raphael","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.019_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1681\/ASN.2014020205","article-title":"Current status of bicarbonate in CKD","volume":"26","author":"Dobre","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.07.019_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ackd.2017.06.005","article-title":"Adverse effects of the metabolic acidosis of chronic kidney disease","volume":"24","author":"Kraut","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2020.07.019_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MNH.0000000000000386","article-title":"Retarding progression of chronic kidney disease: use of modalities that counter acid retention","volume":"27","author":"Kraut","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.019_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.ajkd.2015.12.016","article-title":"Approach to the treatment of chronic metabolic acidosis in CKD","volume":"67","author":"Raphael","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2020.07.019_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.ackd.2017.06.006","article-title":"Management of the metabolic acidosis of chronic kidney disease","volume":"24","author":"Goraya","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.019_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2215\/CJN.07300717","article-title":"Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD","volume":"13","author":"Bushinsky","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10179","key":"10.1053\/j.ajkd.2020.07.019_bib8","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(18)32562-5","article-title":"Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial","volume":"393","author":"Wesson","year":"2019","journal-title":"Lancet"},{"issue":"10196","key":"10.1053\/j.ajkd.2020.07.019_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","article-title":"Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension","volume":"394","author":"Wesson","year":"2019","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2020.07.019_bib10","series-title":"Acid-Base Disorders and Their Treatment","first-page":"209","article-title":"Gastrointestinal influences on hydrogen ion balance","author":"Charney","year":"2005"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.019_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0002-9343(66)90182-3","article-title":"The response of normal man to selective depletion of HCl. Factors in the generation of persistent gastric alkalosis","volume":"40","author":"Kassirer","year":"1966","journal-title":"Am J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2020.07.019_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2215\/CJN.08340812","article-title":"Effects of oral sodium bicarbonate in patients with CKD","volume":"8","author":"Abramowitz","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.019_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2019030287","article-title":"A\u00a0randomized trial comparing the safety, adherence, and pharmacodynamics profiles of two doses of sodium bicarbonate in CKD: the BASE pilot trial","volume":"31","author":"Raphael","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.019_bib14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ki.1986.62","article-title":"Lactic acidosis","volume":"29","author":"Madias","year":"1986","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2020.07.019_bib15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2215\/CJN.01830218","article-title":"Metabolic changes with base-loading in CKD","volume":"13","author":"Scialla","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.019_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2215\/CJN.03020906","article-title":"Serum anion gap: its uses and limitations in clinical medicine","volume":"2","author":"Kraut","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.019_bib17","doi-asserted-by":"crossref","first-page":"F291","DOI":"10.1152\/ajprenal.1978.235.4.F291","article-title":"Changes in the plasma anion gap during chronic metabolic acid-base disturbances","volume":"235","author":"Adrogu\u00e9","year":"1978","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.019_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI110841","article-title":"Influence of steady-state alterations in acid-base equilibrium on the fate of administered bicarbonate in the dog","volume":"71","author":"Adrogu\u00e9","year":"1983","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.019_bib19","first-page":"E419","article-title":"Body elemental composition: comparison between black and white adults","volume":"232","author":"Cohn","year":"1977","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2020.07.019_bib20","series-title":"Clinical Disorders of Fluid and Electrolyte Metabolism","first-page":"1","article-title":"Dynamics of body water and electrolytes","author":"Hays","year":"1980"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.019_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2215\/CJN.11771017","article-title":"New frontiers in treating uremic metabolic acidosis","volume":"13","author":"Brown","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.07.019_bib22","series-title":"Dietary Fiber: Basic and Clinical Aspects","first-page":"131","article-title":"Fermentation and production of short-chain fatty acids in human large intestine","author":"Cummings","year":"1990"},{"issue":"10","key":"10.1053\/j.ajkd.2020.07.019_bib23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1172\/JCI105466","article-title":"The effect of diet and stool composition on the net external acid balance of normal subjects","volume":"45","author":"Lennon","year":"1966","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2020.07.019_bib24","first-page":"1","article-title":"Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): a report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"4","author":"Dobre","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1053\/j.ajkd.2020.07.019_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/j.ajkd.2015.03.032","volume":"66","author":"Schutte","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"2 suppl","key":"10.1053\/j.ajkd.2020.07.019_bib26","doi-asserted-by":"crossref","first-page":"708S","DOI":"10.1093\/ajcn\/65.2.708S","article-title":"Dietary sodium and blood pressure: interactions with other nutrients","volume":"65","author":"Kotchen","year":"1997","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.019_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/HJH.0b013e3283316cfc","article-title":"Selective chloride loading is pressor in the stroke-prone spontaneously hypertensive rat despite hydrochlorothiazide-induced natriuresis","volume":"28","author":"Schmidlin","year":"2010","journal-title":"J\u00a0Hypertens"},{"issue":"8","key":"10.1053\/j.ajkd.2020.07.019_bib28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00004872-198808000-00003","article-title":"A\u00a0randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with\u00a0essential hypertension","volume":"6","author":"Shore","year":"1988","journal-title":"J\u00a0Hypertens"},{"issue":"6, pt 1","key":"10.1053\/j.ajkd.2020.07.019_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.HYP.19.6.541","article-title":"Effects of sodium salts on pressor reactivity in salt-sensitive men","volume":"19","author":"Sharma","year":"1992","journal-title":"Hypertension"},{"issue":"9","key":"10.1053\/j.ajkd.2020.07.019_bib30","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2020.07.019_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2009.519","article-title":"Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR","volume":"77","author":"Phisitkul","year":"2010","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2020.07.019_bib32","first-page":"121","article-title":"Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial","volume":"35","author":"Dubey","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2020.07.019_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5049\/EBP.2014.12.2.80","article-title":"Effect of bicarbonate supplementation on renal function and nutritional indices in predialysis advanced chronic kidney disease","volume":"12","author":"Jeong","year":"2014","journal-title":"Electrolyte Blood Press"},{"issue":"6","key":"10.1053\/j.ajkd.2020.07.019_bib34","first-page":"989","article-title":"Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study","volume":"32","author":"Di Iorio","year":"2019","journal-title":"J\u00a0Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.07.019_bib35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1053\/j.ajkd.2018.09.004","article-title":"Tolerance to sodium in patients with CKD-induced metabolic acidosis: does the accompanying anion matter?","volume":"73","author":"Bushinsky","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2020.07.019_bib36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","article-title":"Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis","volume":"14","author":"Navaneethan","year":"2019","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620309392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620309392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:32:11Z","timestamp":1759462331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620309392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0272638620309392"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.07.019","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Veverimer: An Emerging Potential Treatment Option for Managing the Metabolic Acidosis of CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}